BALTIMORE, May 07, 2026 (GLOBE NEWSWIRE) — Today, the American Urological Association (AUA) released the 2026 Management of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign Prostatic Hyperplasia (BPH) Guideline, providing updated, evidence-based recommendations to support clinicians in the evaluation and management of men with urinary symptoms associated with prostate enlargement.
LUTS attributed to BPH affect millions of men in the United States and are among the most common reasons for urologic office visits, often worsening with age and significantly disrupting sleep, daily activities, and quality of life.
The updated Guideline includes 62 recommendations and reflects newly available clinical evidence, evolving medical therapies, and advances in minimally invasive and surgical treatment options. It emphasizes shared decision-making and individualized care, recognizing that urinary symptoms may result from multiple contributing factors beyond prostate enlargement alone.
“Lower urinary tract symptoms related to benign prostatic hyperplasia can significantly impact quality of life, and managing them requires thoughtful, evidence‑based care,” said Ramy Goueli, MD, MHS, chair of the Guideline. “This updated Guideline provides clinicians with clear, practical recommendations to help ensure patients receive the most appropriate evaluation and treatment based on the best available evidence.”
The Guideline is intended for use in everyday clinical practice and serves as a practical reference for clinicians caring for patients with LUTS/BPH.
This Guideline includes information on:
- Evaluation of LUTS/BPH
- Medical management of LUTS/BPH
- Procedural/surgical management of LUTS/BPH
The full Guideline is now available at AUANet.org/2026BPHGuideline
A summary of the Guideline also appears at:
Goueli R, Badlani GH, Welliver C, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and Evaluation. J Urol. 0(0). doi:10.1097/JU.0000000000005097
https://www.auajournals.org/doi/10.1097/JU.0000000000005097
Goueli R, Badlani GH, Welliver C, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part II: Medical Management. J Urol. 0(0). doi:10.1097/JU.0000000000005098
https://www.auajournals.org/doi/10.1097/JU.0000000000005098
Goueli R, Badlani GH, Welliver C, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III:
Procedural/Surgical Management. J Urol. 0(0). doi:10.1097/JU.0000000000005099
https://www.auajournals.org/doi/10.1097/JU.0000000000005099
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 25,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
Corey Del Bianco American Urological Association 443-909-4033 cdelbianco@auanet.org
Media gallery
